REPORT ATTRIBUTE |
DETAILS |
Historical Period |
2019-2022 |
Base Year |
2023 |
Forecast Period |
2024-2032 |
Cannabis Extract Market Size 2024 |
USD 12,375 Million |
Cannabis Extract Market, CAGR |
17.1% |
Cannabis Extract Market Size 2032 |
USD 43,752.24 Million |
Market Overview:
The Cannabis Extract Market is projected to grow from USD 12,375 million in 2024 to USD 43,752.24 million by 2032, reflecting a compound annual growth rate (CAGR) of 17.1%. This rapid growth is driven by the increasing legalization of cannabis products for both medicinal and recreational use, particularly in North America and parts of Europe. Cannabis extracts, including cannabidiol (CBD) and tetrahydrocannabinol (THC), are gaining popularity due to their versatile applications in pharmaceutical, cosmetic, and food and beverage sectors. With rising consumer awareness about the therapeutic benefits of cannabis extracts, such as pain relief, anti-inflammation, and anxiety reduction, the demand for high-quality and safe extracts is expected to grow significantly over the forecast period.
Key drivers of the cannabis extract market include expanding legalization efforts and increasing consumer demand for natural wellness products. The pharmaceutical industry’s interest in cannabis extracts for treating chronic conditions like epilepsy, multiple sclerosis, and cancer-related symptoms is fueling market growth. Additionally, the cosmetics and personal care sectors are increasingly using CBD extracts for skincare products, driven by claims of antioxidant and anti-aging benefits. Many companies are investing in research and development to enhance extraction techniques and produce high-purity extracts, such as supercritical CO2 extraction, which ensures quality and safety. Furthermore, regulatory advancements and supportive government policies in regions like North America and Europe are encouraging industry growth and fostering a favorable business environment.
Regionally, North America holds the largest share of the cannabis extract market, attributed to early legalization efforts and a well-established infrastructure for cannabis cultivation and processing. The United States and Canada are at the forefront, with significant investments in both medicinal and recreational cannabis markets. Europe is the second-largest market, driven by rising acceptance of cannabis-based medicinal products and supportive regulatory frameworks, especially in countries like Germany and the Netherlands. The Asia-Pacific region is expected to exhibit the fastest growth due to increasing acceptance and legalization in countries like Thailand and Australia. Additionally, the Latin American market shows potential for expansion, with countries like Brazil and Mexico exploring cannabis legalization, particularly for medical purposes. These regional dynamics underscore the global shift towards the acceptance and use of cannabis extracts across multiple industries.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Drivers:
Expanding Legalization and Regulatory Support:
The increasing legalization of cannabis products, particularly in North America and Europe, is a major driver of the cannabis extract market. For example, Canada fully legalized recreational cannabis use in 2018, while numerous states in the U.S. have either legalized or decriminalized cannabis for medicinal and/or recreational use. According to the U.S. Congressional Research Service, as of 2024, 38 U.S. states have legalized medical cannabis, and 23 allow recreational use. Additionally, European countries such as Germany and the Netherlands have established frameworks for medical cannabis, encouraging the growth of cannabis extracts in the pharmaceutical sector. These regulatory changes are creating a more favorable business environment and encouraging investment in cannabis extract production.
Rising Demand for Therapeutic and Medicinal Applications:
Cannabis extracts, particularly cannabidiol (CBD), are increasingly recognized for their therapeutic benefits, fueling market demand. The World Health Organization (WHO) has noted that CBD shows promise in treating conditions such as epilepsy, anxiety, and chronic pain. In fact, the U.S. Food and For instance, Drug Administration (FDA) approved Epidiolex, a CBD-based drug, for the treatment of certain epilepsy syndromes, which underscores the medical potential of cannabis extracts. Pharmaceutical companies are investing in research to explore the use of THC and CBD extracts in managing symptoms related to multiple sclerosis, cancer, and other chronic diseases. This increasing medical recognition drives demand for high-quality cannabis extracts in the healthcare sector.
Growth in Health and Wellness Industry:
The health and wellness industry have seen a surge in demand for natural and plant-based products, including cannabis extracts. For instance, the global wellness industry reported a growing consumer shift towards natural remedies, with CBD products becoming popular for stress relief, improved sleep, and skincare benefits. The American Herbal Products Association (AHPA) reported that CBD-based wellness products, such as oils, topicals, and edibles, are increasingly sought after by consumers seeking alternatives to traditional pharmaceuticals. Moreover, the skincare industry is incorporating CBD extracts for their antioxidant and anti-inflammatory properties, driving further growth in the cannabis extract market.
Advancements in Extraction and Purification Technologies:
Technological advancements in extraction methods, such as supercritical CO2 extraction, are enhancing the quality and purity of cannabis extracts, contributing to market growth. Supercritical CO2 extraction is considered one of the safest methods, as it avoids the use of harmful solvents, producing high-purity extracts suitable for medicinal and wellness applications. Companies are investing in these technologies to improve efficiency and product consistency. For example, companies like Aurora Cannabis have integrated advanced extraction systems to enhance product quality and meet the stringent safety standards required for medical applications. This focus on technology and safety aligns with consumer demand for reliable, high-quality cannabis extract products.
Market Trends:
Expanding Legalization and Regulatory Support:
The increasing legalization of cannabis products, particularly in North America and Europe, is a major driver of the cannabis extract market. For example, Canada fully legalized recreational cannabis use in 2018, while numerous states in the U.S. have either legalized or decriminalized cannabis for medicinal and/or recreational use. According to the U.S. Congressional Research Service, as of 2024, 38 U.S. states have legalized medical cannabis, and 23 allow recreational use. Additionally, European countries such as Germany and the Netherlands have established frameworks for medical cannabis, encouraging the growth of cannabis extracts in the pharmaceutical sector. These regulatory changes are creating a more favorable business environment and encouraging investment in cannabis extract production.
Rising Demand for Therapeutic and Medicinal Applications:
Cannabis extracts, particularly cannabidiol (CBD), are increasingly recognized for their therapeutic benefits, fueling market demand. The World Health Organization (WHO) has noted that CBD shows promise in treating conditions such as epilepsy, anxiety, and chronic pain. For instance, in fact, the U.S. Food and Drug Administration (FDA) approved Epidiolex, a CBD-based drug, for the treatment of certain epilepsy syndromes, which underscores the medical potential of cannabis extracts. Pharmaceutical companies are investing in research to explore the use of THC and CBD extracts in managing symptoms related to multiple sclerosis, cancer, and other chronic diseases. This increasing medical recognition drives demand for high-quality cannabis extracts in the healthcare sector.
Growth in Health and Wellness Industry:
The health and wellness industry have seen a surge in demand for natural and plant-based products, including cannabis extracts. For instance, the global wellness industry reported a growing consumer shift towards natural remedies, with CBD products becoming popular for stress relief, improved sleep, and skincare benefits. The American Herbal Products Association (AHPA) reported that CBD-based wellness products, such as oils, topicals, and edibles, are increasingly sought after by consumers seeking alternatives to traditional pharmaceuticals. Moreover, the skincare industry is incorporating CBD extracts for their antioxidant and anti-inflammatory properties, driving further growth in the cannabis extract market.
Advancements in Extraction and Purification Technologies
Technological advancements in extraction methods, such as supercritical CO2 extraction, are enhancing the quality and purity of cannabis extracts, contributing to market growth. Supercritical CO2 extraction is considered one of the safest methods, as it avoids the use of harmful solvents, producing high-purity extracts suitable for medicinal and wellness applications. Companies are investing in these technologies to improve efficiency and product consistency. For example, companies like Aurora Cannabis have integrated advanced extraction systems to enhance product quality and meet the stringent safety standards required for medical applications. This focus on technology and safety aligns with consumer demand for reliable, high-quality cannabis extract products.
Market Challenges Analysis:
Stringent Regulatory Requirements and Compliance Costs:
The cannabis extract market is subject to complex and often inconsistent regulations across regions, which can restrict market growth and complicate compliance. For instance, in the United States, the U.S. Food and Drug Administration (FDA) has limited cannabis-derived products to specific therapeutic claims, such as CBD for epilepsy under the drug Epidiolex, while restricting broader health claims. Similarly, the European Medicines Agency (EMA) enforces rigorous standards for cannabis extracts, requiring extensive clinical trials and evidence before approval. These regulatory barriers add significant compliance costs for companies, which can hinder innovation and delay product launches.
High Production and Extraction Costs:
The extraction of high-quality cannabis extracts requires advanced technology and significant energy consumption, which drives up costs. Methods such as supercritical CO2 extraction, while effective for producing pure extracts, demand expensive equipment and technical expertise. Additionally, energy-intensive processes can lead to elevated operational costs, making it difficult for smaller enterprises to compete. The American Society for Testing and Materials (ASTM) has established standards for extraction methods, adding further costs for equipment and training to ensure compliance. High production costs can result in elevated product prices, limiting accessibility and market expansion.
Public Safety Concerns and Quality Control Issues:
Public safety concerns about cannabis products, particularly related to THC content, remain a significant challenge. The FDA has raised concerns regarding unregulated products, which can lead to inconsistencies in potency and contamination. This lack of standardization affects consumer trust and can result in legal repercussions for manufacturers if products do not meet local quality and safety standards. Additionally, variations in state and federal guidelines on THC limits in the U.S. create challenges for producers, who must navigate different requirements to ensure compliance.
Social Stigma and Limited Consumer Awareness:
Despite increasing acceptance, cannabis extracts continue to face social stigma, which can affect consumer perceptions and market demand. Many consumers remain uncertain about the safety and benefits of cannabis-based products due to historical biases and misinformation. The National Institute on Drug Abuse (NIDA) has pointed out that public misconceptions about cannabis persist, often conflating medical CBD products with recreational marijuana. This stigma, combined with limited awareness of the potential therapeutic uses of cannabis extracts, restricts the market’s ability to reach a broader consumer base, particularly in regions where legalization is still evolving.
Market Segmentation Analysis:
By Type:
The market includes various types of cannabis extracts, primarily cannabidiol (CBD), tetrahydrocannabinol (THC), and a range of other cannabinoids, such as cannabigerol (CBG) and cannabinol (CBN). CBD extracts are the most widely used due to their non-psychoactive properties and therapeutic benefits, making them popular for wellness and medical applications. THC extracts, while subject to stricter regulations, are in demand for both medical and recreational uses, where permitted. CBG and CBN are emerging as niche segments, driven by interest in their specific therapeutic effects.
By Technology:
Cannabis extract production utilizes several extraction technologies, including supercritical CO2 extraction, solvent-based extraction, and ethanol extraction. Supercritical CO2 extraction is considered the gold standard due to its ability to produce high-purity extracts without harmful solvents, aligning with stringent safety requirements. Solvent-based extraction methods, such as butane and propane, offer cost-effective solutions but are typically used in regions with fewer regulatory restrictions. Ethanol extraction is also widely adopted, especially for producing full-spectrum extracts, as it retains a broader range of cannabinoids and terpenes.
By End User:
The primary end users of cannabis extracts are the pharmaceutical, food and beverage, and cosmetics and personal care industries. The pharmaceutical sector is a major end user, incorporating cannabis extracts into treatments for conditions such as epilepsy, chronic pain, and anxiety. The food and beverage industry leverages CBD extracts in functional foods, beverages, and supplements, while the cosmetics and personal care industry incorporates CBD into products for skincare, leveraging its anti-inflammatory and antioxidant properties. This segmentation highlights the versatility of cannabis extracts and their expanding role across multiple consumer-facing industries.
Segmentations:
By Type
By Extraction Method
By Application
- Textile
- Cosmetic
- Pharmaceutical
- Paper
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
Regional Analysis:
North America
North America holds the largest share of the cannabis extract market, accounting for approximately 40% of global market revenue. This dominance is driven by early legalization efforts, particularly in the United States and Canada, where cannabis is legal for both medicinal and recreational use in various states and provinces. Canada, which fully legalized recreational cannabis in 2018, has a well-developed infrastructure for cannabis cultivation, processing, and distribution. The United States, with over 38 states legalizing medical cannabis and 23 permitting recreational use, has seen substantial investment in cannabis extract production. The presence of major industry players and an advanced regulatory framework support innovation and high product quality, further reinforcing North America’s leadership position in the market.
Europe
Europe represents around 25% of the global cannabis extract market share, with increasing acceptance of cannabis-based medicinal products. Countries like Germany, the United Kingdom, and the Netherlands are leaders in medical cannabis use, supported by favorable government policies and regulatory frameworks. Germany’s decision to reimburse medical cannabis through public health insurance has significantly boosted the market. Additionally, the European Medicines Agency (EMA) has granted approvals for specific cannabis-based drugs, such as Epidiolex, which is used for treating epilepsy. However, recreational cannabis remains largely illegal across Europe, limiting the market to primarily medicinal applications. As more European nations explore cannabis legalization and align their policies, the region’s market share is expected to grow.
Asia-Pacific
Asia-Pacific is anticipated to exhibit the fastest growth in the cannabis extract market, capturing approximately 20% of the market share. This growth is driven by increasing legalization and progressive policies in countries such as Thailand, Australia, and New Zealand. Thailand, for example, became the first Southeast Asian nation to legalize medical cannabis in 2018, paving the way for cannabis cultivation and extract production. In Australia, medical cannabis use is expanding, supported by government initiatives and a growing body of clinical research. Additionally, rising consumer interest in natural wellness products, including CBD-infused products, is fueling demand. However, stringent regulations in many Asian countries, such as Japan and China, where cannabis remains illegal, continue to limit market growth.
Latin America
Latin America holds around 10% of the global market share, driven by progressive legalization in countries like Brazil, Mexico, and Uruguay. Uruguay became the first country to fully legalize cannabis in 2013, setting a precedent for other Latin American nations. In Mexico, the legalization of medical cannabis has opened new market opportunities, and recreational use is under legislative consideration. Brazil has also approved cannabis-based medicinal products, albeit under strict regulations. However, economic constraints and varying regulatory standards across the region present challenges for market expansion.
Middle East & Africa
The Middle East & Africa account for approximately 5% of the cannabis extract market share. Demand is primarily driven by South Africa, where cannabis is legal for personal use and medical applications are gaining traction. Additionally, countries like Israel are advancing research on cannabis extracts, particularly for medical purposes, as the country is recognized as a leader in cannabis research and development. However, conservative cultural perspectives and legal restrictions in many parts of the Middle East limit market growth. Nevertheless, as regulations evolve, the region has the potential to expand its cannabis extract market, especially within medical and wellness sectors.
Key Player Analysis:
- Canopy Growth Corporation
- Aurora Cannabis Inc.
- Tilray, Inc.
- Cronos Group Inc.
- GW Pharmaceuticals (acquired by Jazz Pharmaceuticals)
- Curaleaf Holdings, Inc.
- Aphria Inc. (now part of Tilray)
- Charlotte’s Web Holdings, Inc.
- MediPharm Labs Corp.
- Green Thumb Industries Inc.
Competitive Analysis:
The cannabis extract market is highly competitive, driven by key players such as Canopy Growth Corporation, Aurora Cannabis, and Tilray, Inc., who lead through strategic acquisitions, diversified product offerings, and robust research and development efforts. These companies focus on expanding their product portfolios to include a variety of extracts like CBD, THC, and full-spectrum formulations, catering to the pharmaceutical, wellness, and personal care industries. Intense competition is also fueled by regulatory advancements, particularly in North America and Europe, which allow established companies to innovate and scale more quickly. Additionally, smaller players like Charlotte’s Web Holdings and MediPharm Labs capitalize on niche markets, emphasizing product purity and sustainable extraction methods. This competitive landscape is further shaped by advancements in extraction technology, such as supercritical CO2 extraction, which ensures high-quality products while meeting safety standards. Overall, the cannabis extract market is marked by rapid innovation and strategic positioning as companies vie to meet growing consumer demand.
Recent Developments:
- In 2024, Canopy Growth confirmed the acquisitions of Wana Brands and Jetty Extracts through its subsidiary Canopy USA. This move allows Canopy to expand its presence in the U.S. market by incorporating Wana’s edibles and Jetty’s high-quality vape products into its portfolio. This acquisition is part of Canopy USA’s broader strategy to establish a diverse range of cannabis offerings in U.S. state-legal markets.
- In early 2024, Canopy introduced a series of new pre-roll products under its 7ACRES and Hiway brands. These include the 7ACRES Smooth Burners, which are designed for a slower burn, and Hiway’s Water Hash Infused pre-rolls, which combine bubble hash with premium cannabis. This product launch highlights Canopy’s commitment to catering to a variety of consumer preferences with innovative and high-quality products.
- Wana, a brand under Canopy USA, launched Wanderous in 2023, a direct-to-consumer marketplace offering hemp-derived products such as Delta-9-THC and CBD gummies. The platform features products from top brands like Martha Stewart CBD and Charlotte’s Web, providing consumers with a curated selection of wellness-focused cannabis products.
- In June 2024, Canopy Growth established a US$250 million at-the-market (ATM) equity program, enabling the company to raise capital by selling common shares as needed. This financial move aims to enhance Canopy’s balance sheet and support future growth initiatives, including further expansion into international markets and product innovation.
Market Concentration & Characteristics:
The cannabis extract market is moderately concentrated, with major players such as Canopy Growth, Aurora Cannabis, and Tilray holding significant shares due to their extensive product portfolios, advanced extraction technologies, and broad geographic reach. These companies dominate through strategic mergers and acquisitions, diverse offerings including CBD and THC extracts, and ongoing investment in research and development to enhance product purity and consistency. High entry barriers, including stringent regulatory requirements from agencies like the FDA and EMA, restrict new market entrants and reinforce the position of established players. The market is characterized by rapid innovation in extraction methods, such as supercritical CO2 and ethanol extraction, which ensures high-quality and safe products for both medicinal and recreational applications. Additionally, the competitive landscape is shaped by growing consumer demand for plant-based wellness products and increasing legalization across North America and parts of Europe, fostering a favorable environment for market expansion.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage:
The research report offers an in-depth analysis based on Type, Extraction Method, Application, and Distribution Channel. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- Growing legalization of cannabis in North America, Europe, and parts of Asia-Pacific will continue to expand the market.
- Advancements in extraction technologies, such as supercritical CO2 and ethanol extraction, will enhance product purity and safety.
- Rising consumer interest in natural wellness products, including CBD oils and THC extracts, will drive demand as consumers seek alternatives to traditional pharmaceuticals for relaxation, pain management, and stress relief.
- Increased focus on sustainability will prompt companies to adopt eco-friendly extraction methods and reduce the environmental impact of cannabis cultivation and processing.
- Expansion into the pharmaceutical sector will continue as clinical research uncovers new therapeutic applications for cannabis extracts in treating conditions like epilepsy, anxiety, and chronic pain.
- The food and beverage industry will increasingly incorporate cannabis extracts into functional products such as beverages, snacks, and supplements, expanding market reach.
- Regulatory advancements, particularly in Europe and Latin America, will support market growth by providing clearer guidelines and legal pathways for cannabis extract use in medicinal and wellness applications.
- Strategic partnerships and mergers among key players will strengthen their market positions and enhance R&D capabilities, accelerating product innovation and market expansion.
- Digital platforms and direct-to-consumer channels will become increasingly popular, enabling companies to reach a broader audience.
- Enhanced consumer education and awareness campaigns will reduce stigma, fostering a more favorable market environment.